Patent filings at the European Patent Office: a new record
Last year patent filings at the European Patent Office (EPO) grew by 2.8%, which is a new record. According to the EPO President Benoît Battistelli, “this is proof that companies from around the world continue to see Europe more and more as a premier hub for innovation”.
As in previous years, most patent filings in 2013 came from outside Europe, particularly the US and Japan.
Secondary condition, sample viagra which is the high blood pressure or hypertension should not take this medicine. The short toe is not pulling its weight while the neighboring bones viagra buy online get overworked. As men with erection problems looks for help as a solution towards the suffering from the problem levitra 5mg online of getting it up or keeping it up during intercourse. Because it is the parallel medicine of sildenafil 50mg price and contains the exact amount of the active ingredient, Sildenafil, as does levitra and is made by the reputable pharmaceutical company, Eli Lily.
The EPO highlighted that “European industry maintained its patenting activities at the same level as in the previous year, with marked regional differences, however.” The highest growth rates come from the Netherlands (+17.2%), Denmark (+8.1%), Sweden (+7.5%) but also member states with lower filing levels, such as Portugal (+34.5%), the Czech Republic (+26.5%) and Ireland (+9.4%). Even though Germany has seen a drop in the number of patent filings, it is still the EU member state with the highest percentage of patent filings at the EPO.
For further information, http://www.epo.org/news-issues/press/releases/archive/2014/20140306.html